Format

Send to

Choose Destination
J Arthroplasty. 2018 Feb;33(2):331-336. doi: 10.1016/j.arth.2017.09.001. Epub 2017 Sep 13.

Persistent Opioid Use Following Total Knee Arthroplasty: A Signal for Close Surveillance.

Author information

1
Department of Orthopaedic Surgery, Southern California Permanente Medical Group, Irvine, California.
2
Medicine and Devices Surveillance Centre of Research Excellence, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia.
3
Australian Orthopaedic Association National Total Joint Replacement Registry, Adelaide, South Australia.
4
Surgical Outcomes and Analysis, Kaiser Permanente, San Diego, California.

Abstract

BACKGROUND:

Prolonged opioid use following total knee arthroplasty (TKA) has not been extensively studied.

METHODS:

A cohort study of primary TKA for osteoarthritis using an integrated healthcare system and Total Joint Replacement Registry (January 2008-December 2011) was conducted. Opioid use during the first year after TKA was the exposure of interest and cumulative daily oral morphine equivalent (OME) amounts were calculated. Total postsurgical OME per 90-day exposure periods were categorized into quartiles. The end point was aseptic revision surgery. Survival analyses were conducted and hazard ratios (HRs) were adjusted for age, gender, prior analgesic use, opioid-related comorbidities, and chronic pain diagnoses.

RESULTS:

A total of 24,105 patients were studied. After the initial 90-day postoperative period, 41.5% (N = 9914) continued to use opioids. Also, 155 (0.6%) revisions occurred within 1 year and 377 (1.6%) within 5 years. Compared to patients not taking any opioids, patients using medium-low to high OME after the initial 90-day period had a higher adjusted risk of 1-year revision, ranging from HR = 2.4 (95% confidence interval, 1.3-4.5) to HR = 33 (95% confidence interval, 10-110) depending on the OME and time period.

CONCLUSION:

Patients who require opioids beyond 90 days after TKA warrant close follow-up.

KEYWORDS:

TKA; follow-up; level 2; postoperative; prolonged opioid use; revision risk; surveillance

PMID:
28974377
DOI:
10.1016/j.arth.2017.09.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center